Prospective multi-center study of the impact of Oncotype® DX Colon Cancer Assay results on treatment recommendations in stage II colon cancer patients

被引：0
|
作者：
Srivastava, G. [1 ]
Renfro, L. A. [1 ]
Behrens, R. J. [2 ]
Lopatin, M. [3 ]
Chao, C. [3 ]
Soori, G. S. [4 ]
Dakhil, S. R. [5 ]
Kim, G. [6 ]
Lee, M. [3 ]
Alberts, S. R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Med Oncol & Hematol Associates, Oncol, Des Moines, IA USA
[3] Genom Hlth Inc, Red Wood City, CA USA
[4] Alegent Bergen Mercy Canc Ctr, Omaha, NE USA
[5] Canc Ctr Kansas, Wichita, KS USA
[6] Mayo Clin, Jacksonville, FL 32224 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2184
引用
收藏
页码：S493 / S493
页数：1
相关论文
共 50 条
  • [31] IMPACT OF ADJUVANT CHEMOTHERAPY ON SURVIVAL OF PATIENTS WITH STAGE II COLON CANCER: RETROSPECTIVE STUDY
    ElAlfy, Eman
    ElKerm, Yasser
    Zaky, Sameh
    Kandil, Alaa
    ANNALS OF ONCOLOGY, 2011, 22 : v117 - v118
  • [32] IMPACT OF ADJUVANT CHEMOTHERAPY ON SURVIVAL OF PATIENTS WITH STAGE II COLON CANCER: RETROSPECTIVE STUDY
    El Alfy, E. S.
    Kandil, A. S.
    Zaki, S. I.
    El Kerm, Y. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 221 - 221
  • [33] Impact of adjuvant chemotherapy on survival for patients with Stage II colon cancer
    Stitzenberg, K. B.
    Stewart, A.
    Palis, B.
    Bilimoria, K.
    Minsky, B.
    Sigurdson, E.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 89 - 89
  • [34] The Impact of Oncotype DX Breast Cancer Assay Results on Clinical Practice - a UK Experience
    Crolley, V.
    Rawther, S.
    Chaabouni, N.
    Rigg, A.
    Wadhawan, A.
    King, J.
    CLINICAL ONCOLOGY, 2017, 29 (06) : E98 - E99
  • [35] The impact of Oncotype DX breast cancer assay results on clinical practice: A UK experience
    Crolley, V. E.
    Marashi, H.
    Rawther, S. K. R.
    Parton, M.
    Graham, J.
    Vinayan, A.
    Sutherland, S.
    Rigg, A.
    Wadhawan, A.
    Harper-Wynne, C.
    Spurrell, E.
    Bond, H.
    Raja, F.
    King, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Crolley, Valerie E.
    Marashi, Husam
    Rawther, Shabbir Khan Rajan
    Sirohi, Bhawna
    Parton, Marina
    Graham, Janine
    Vinayan, Anup
    Sutherland, Stephanie
    Rigg, Anne
    Wadhawan, Anshu
    Harper-Wynne, Catherine
    Spurrell, Emma
    Bond, Hannah
    Raja, Fharat
    King, Judy
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 557 - 558
  • [37] Prospective multi-center study colon/rectum carcinoma (primary tumors) -: Results of the year 2000
    Marusch, F
    Koch, A
    Schmidt, U
    Geissler, S
    Meyer, L
    Jost, J
    Ulrich, B
    Gastinger, I
    Köckerling, F
    Lippert, H
    ZENTRALBLATT FUR CHIRURGIE, 2002, 127 (04): : 332 - 337
  • [38] Body Mass Index (BMI) Dependent Outcome in Colon Cancer(CA) Surgery - Interims Results of a Prospective Multi-Center Observational Study
    Kreyer, Homy
    Otto, Ronny
    Lippert, Hans
    Gastinger, Ingo
    Ptok, Henry
    Croner, Roland S.
    Meyer, Frank
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 53 - 53
  • [39] Impact of the Immunoscore® assay on adjuvant chemotherapy decision making in patients with resected stage II-III colon cancer: A prospective, multicenter study (PROSCORE)
    Malka, D.
    Mollevi, C.
    Hermitte, F.
    Catteau, A.
    Lachaux, N.
    Jouffroy, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients
    Bae, Susie
    Wong, Hui-Li
    Tie, Jeanne
    Desai, Jayesh
    Field, Kathryn
    Kosmider, Suzanne
    Fourlanos, Spiros
    Jones, Ian
    Skinner, Iain
    Gibbs, Peter
    JOURNAL OF CANCER EPIDEMIOLOGY, 2015, 2015
12345